Apoglyx Competitors and Similar CompaniesClear all
Apoglyx's competitors and similar companies include Carmot Therapeutics, BIOTON, Enthera Pharmaceuticals and Viking Therapeutics.
 Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. |  Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. |  Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. |  Viking Therapeutics Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders. | ||
Founding Date | Founding Date 2015 | Founding Date 2008 | Founding Date 1989 | Founding Date 2016 | Founding Date 2012 |
Type | Type Private | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Malmö, SE HQ Lund, SE | Locations Berkeley, US HQ | Locations Macierzysz, PL HQ | Locations Milan, IT HQ Milan, IT Milan, IT | Locations San Diego, US HQ |
Employees | Employees 525% increase | Employees 109% decrease | Employees 361 | Employees 225% increase | Employees 2729% increase |
Financial | |||||
Net income | Net income N/A | Net income ($38.8m) (FY, 2022) | Net income zł3.4m (FY, 2025) | Net income N/A | Net income ($359.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 74.8m | Total funding raised N/A | Total funding raised $ 32.8m | Total funding raised $ 15m |
For sources of this data, please see the company profile
View Company Profiles
Carmot Therapeutics
HQ
Berkeley, US
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View company
BIOTON
HQ
Macierzysz, PL
Employees
361
Bioton is a biotech company whose major therapeutic area is diabetes.
View companyEnthera Pharmaceuticals
HQ
Milan, IT
Employees
22↑ 5% increase
Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.
View companyViking Therapeutics
HQ
San Diego, US
Employees
27↑ 29% increase
Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders.
View company